Innova Captab Limited (INNOVACAP) Share Price
NSE · Healthcare · Drug Manufacturers - Specialty & Generic · ISIN INE0DUT01020
Key metrics
- Market Cap
- ₹5,846 Cr
- P/E Ratio
- 37.95
- EPS
- 26.92
- Book Value
- 190.61
- P/B Ratio
- 5.38
- ROE
- 12.92%
- ROCE
- 13.05%
- Debt / Equity
- 0.32
- Net Margin
- 8.79%
- Revenue Growth
- 29.93%
- Profit Growth
- 9.87%
- Dividend Yield
- 0.39%
- 52W High
- ₹1,120.00
- 52W Low
- ₹622.00
- Market Cap Band
- mid cap
- Face Value
- 10
Ratios computed from the annual results period ending 2026-03-31.
About Innova Captab Limited
Innova Captab Limited, an integrated pharmaceutical company, engages in the research and development, manufacture, distribution, and marketing of drugs and pharmaceutical products in India and internationally. The company provides contract development and manufacturing organization services to Indian pharmaceutical companies. It is also offers various generic formulation products, including cephalosporins, proton pump inhibitor, anticholinergic and heparin NSAIDs, analgesics and antipyretic, anticold and antiallergic, antiemetic, antidiabetic, antispasmodic, antifibrinolytic, cardiovascular, antioxidant and vitamins, antihyperuricemia and antigout, fluoroquinolone and macrolide, nootropics and neurotonics/neurotrophics, antiulcerative, antimalarial anxiolytic, anticonvulsant and antipsychotic, bladder and prostate disorder, antifungal, anthelmintic and antiviral, anticholinergic, anti-asthmatic, and bronchodilator products in the form of tablets, capsules, dry syrups, dry powder injection, ointments, and liquid orals. The company sells its branded generic products through a network of distributors, stockists, and pharmacies, as well as online channels in various e-commerce pharmacy sites. Innova Captab Limited was incorporated in 2005 and is based in Panchkula, India.
- Headquarters
- Panchkula, India
- Promoter Holding
- 72.19%
The full Innova Captab Limited analysis
Create a free account to open the complete INNOVACAP deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.